Idera Reviews

Recommend to a friend
Approve of CEO
Idera CEO, Chief Scientific Officer, and Director Sudhir Agrawal
Sudhir Agrawal
1 Rating
  • Challenging and educational

    • Work/Life Balance
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee in Cambridge, MA
    Current Employee - Anonymous Employee in Cambridge, MA
    Disapproves of CEO


    Small company, clean and spacious environment, diversity of work and people, state of the art labs, scientific expertise, some longtime staff still in place for company and product history, physical location in the heart of biotech/drug community and MIT.


    Senior management does not want to listen to staff and hear the sometimes difficult truth about a product or outcomes. Small company mindset can often lead to narrow viewpoints and lessen the diversity of innovative people and pipeline. Limitation of capital and resources is often inherent in such a small company.

    Advice to Management

    Learn from mistakes and stop repeating them. Actively listen to staff on a regular basis (Company meetings? hello!) and communicate decisions to all staff in a timely manner in order to improve workflows, establish better processes and SOPs. Focus on product development, technical innovation paths, and new strategic alliances. Don't work in a silo or ivory tower - either at the company or within industry.

Idera Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Cambridge, MA
Size 16 to 50 Employees
Founded Unknown
Type Company - Public (IDRA)
Industry Biotech & Pharmaceuticals
Revenue Less than $1 million (USD) per year

Idera Pharmaceuticals is open to the idea of tinkering with your immune system. The biotech firm is developing DNA and RNA therapies that manipulate the immune system's response to disease. It is focused on Toll-Like Receptors (TLRs) -- immune cell receptors that recognize and respond to viral and bacterial invaders. Some of Idera's drugs (such as treatments for infectious disease and cancer) mimic those invaders to stimulate an immune response; others (including treatments for autoimmune and inflammatory diseases) target TLRs to suppress the immune response. The ... More

Work at Idera? Share Your Experiences


Click to Rate